Sun Pharma does away with losing streak, turns positive
DSIJ Intelligence / 10 Aug 2017
Sun Pharmaceuticals has eased the pressure on the market participants by turning positive during the first trading half of Thursday. The stock is off its record four-year low of Rs 472 per share.
Sun Pharmaceuticals has eased the pressure on the market participants by turning positive during the first trading half of Thursday. The stock is off its record four-year low of Rs 472 per share. It has lost nearly 40% in the past one year. Going back further, the stock has lost around 60% from its record high price of Rs 1,151 per share on April 7, 2015.
The company has lost around Rs 1.25 lakh crore in market capitalisation. However, it still holds the top position in the list of market capitalisation of pharmaceutical companies. The company's full market cap as of August 9, 2017 stood at Rs 1,13,904.22 lakh crore on the BSE.
The Nifty Pharma index has been trading in positive territory during the morning hour on Thursday. The index was trading at the 8,787 level, up by 21 points at 0.25% as of 1124 hours on Wednesday.
Aurobindo Pharma was the top gainer on the index, trading at Rs 702 per share, up by Rs 18.4 or 2.69%. Other pharmaceutical stocks like Lupin, Dr Reddy’s and Sun Pharma were also trading higher by more than 1%.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.